LeMaitre Vascular market cap is $1 b, and annual revenue was $129.37 m in FY 2020

LeMaitre Vascular Gross profit (FY, 2020)84.6 M

LeMaitre Vascular Gross profit margin (FY, 2020), %65.4%

LeMaitre Vascular Net income (FY, 2020)21.2 M

LeMaitre Vascular EBIT (FY, 2020)28.8 M

LeMaitre Vascular Cash, 31-Dec-202026.8 M

LeMaitre Vascular EV996.5 M

LeMaitre Vascular revenue was $129.37 m in FY, 2020

LeMaitre Vascular revenue breakdown by business segment: 51.0% from Lower Extremities, 31.0% from Carotid Artery and 18.0% from Other Areas

LeMaitre Vascular revenue breakdown by geographic segment: 53.9% from United States, 10.6% from Germany and 35.6% from Other Countries

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Revenue | 100.9m | 105.6m | 117.2m | 129.4m |

| 5% | 11% | ||

## Cost of goods sold | 30.2m | 31.6m | 37.4m | 44.7m |

## Gross profit | 70.7m | 73.9m | 79.9m | 84.6m |

| 70% | 70% | 68% | 65% |

## Sales and marketing expense | 25.9m | 27.3m | 30.3m | 23.7m |

## R&D expense | 6.6m | 8.2m | 9.3m | 10.1m |

## General and administrative expense | 17.0m | 17.7m | 19.1m | 22.5m |

## Operating expense total | 49.6m | 45.7m | 58.7m | 55.8m |

## EBIT | 21.1m | 28.2m | 21.2m | 28.8m |

| 21% | 27% | 18% | 22% |

## Interest expense | 21.0k | 2.0k | ||

## Interest income | 179.0k | 631.0k | 698.0k | 207.0k |

## Pre tax profit | 21.1m | 28.4m | 21.7m | 27.4m |

## Income tax expense | 3.9m | 5.5m | 3.7m | 6.1m |

## Net Income | 17.2m | 22.9m | 17.9m | 21.2m |

## EPS | 0.9 | 1.1 | 0.9 |

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Cash | 19.1m | 26.3m | 11.8m | 26.8m |

## Accounts Receivable | 15.0m | 15.7m | 16.6m | 19.6m |

## Prepaid Expenses | 2.6m | 2.9m | 3.3m | 2.6m |

## Inventories | 21.0m | 27.4m | 39.5m | |

## Current Assets | 80.3m | 94.0m | 92.1m | 94.3m |

## PP&E | 12.4m | 14.1m | 14.9m | 15.0m |

## Goodwill | 23.8m | 29.9m | 40.0m | 65.9m |

## Total Assets | 126.3m | 153.1m | 188.3m | 252.8m |

## Accounts Payable | 1.5m | 1.7m | 2.6m | 2.4m |

## Short-term debt | 1.8m | 4.5m | ||

## Current Liabilities | 13.2m | 19.8m | 20.9m | 25.1m |

## Long-term debt | 14.0m | 14.8m | ||

## Total Debt | 15.7m | 19.2m | ||

## Total Liabilities | 16.6m | 22.9m | 40.2m | 80.2m |

## Common Stock | 207.0k | 211.0k | 217.0k | 221.0k |

## Preferred Stock | ||||

## Additional Paid-in Capital | 93.1m | 98.4m | 105.9m | 114.9m |

## Retained Earnings | 28.3m | 45.8m | 57.0m | 70.6m |

## Total Equity | 109.8m | 130.2m | 148.1m | 172.6m |

## Debt to Equity Ratio | 0.1 x | |||

## Debt to Assets Ratio | 0.1 x | |||

## Financial Leverage | 1.2 x | 1.2 x | 1.3 x | 1.5 x |

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Net Income | 17.2m | 22.9m | 17.9m | 21.2m |

## Depreciation and Amortization | 4.1m | 4.3m | 5.4m | 8.4m |

## Accounts Receivable | (1.5m) | (1.3m) | (1.3m) | (939.0k) |

## Inventories | (1.4m) | (4.3m) | (11.3m) | |

## Accounts Payable | 1.5m | 4.3m | (596.0k) | 4.3m |

## Cash From Operating Activities | 22.9m | 19.5m | 14.2m | 34.8m |

## Purchases of PP&E | (6.4m) | (3.1m) | (3.8m) | (3.0m) |

## Cash From Investing Activities | (29.0m) | (7.1m) | (24.1m) | (52.9m) |

## Long-term Borrowings | (25.0m) | |||

## Dividends Paid | (4.2m) | (5.4m) | (6.7m) | (7.7m) |

## Cash From Financing Activities | 80.0k | (4.4m) | (4.6m) | 32.2m |

## Net Change in Cash | (5.2m) | 7.2m | (14.5m) | 15.0m |

USD | Q1, 2017 |
---|---|

## Financial Leverage | 1.2 x |